ClearPoint Neuro, Inc. (Nasdaq: CLPT)
Building on the imaging power of MRI, ClearPoint Neuro is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The company's ClearPoint® system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing MRI suite to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, ClearPoint Neuro is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.
ClearPoint Neuro, Inc.